Innovating Works
STOPSTORM: A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE ENTRANT TACHYCARDIA GORNOSLASKIE CENTRUM MEDYCZNE IM. PROF. LESZKA GIECA SLASKIEGO UNIWERSYTETU MEDYCZNEGO W KATOWICACH participó en un H2020: H2020-SC1-BHC-2018-2020 Ventricular tachycardia (VT) is an unpredictable and potentially deadly condition and should be promptly treated with catheter ablation and...
2021-01-21 - 2027-04-30 | Financiado
ReGenHeart: Clinical development and proof of principle testing of new regenerative VEGF D therapy for cost effe... GORNOSLASKIE CENTRUM MEDYCZNE IM. PROF. LESZKA GIECA SLASKIEGO UNIWERSYTETU MEDYCZNEGO W KATOWICACH participó en un H2020: H2020-SC1-2016-2017 Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately c...
2016-12-01 - 2022-12-31 | Financiado
SCIENCE: Stem Cell therapy in IschEmic Non treatable Cardiac diseasE SCIENCE GORNOSLASKIE CENTRUM MEDYCZNE IM. PROF. LESZKA GIECA SLASKIEGO UNIWERSYTETU MEDYCZNEGO W KATOWICACH participó en un H2020: H2020-PHC-2014-2015 Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) With more than 17 million deaths worldwide each year, ischemic heart...
2014-12-03 - 2020-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.